HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Contrast Anthropomorphic Breast Phantoms. The project location is USA and the tender is closing on 18 Sep 2023. The tender notice number is 75F40123Q00399, while the TOT Ref Number is 88704896. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Contrast Anthropomorphic Breast Phantoms

Deadline : 18 Sep 2023

Other Information

Notice Type : Tender

TOT Ref.No.: 88704896

Document Ref. No. : 75F40123Q00399

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

The U.S. Food & Drug Administration (FDA) intends to issue a Sole Source award to Phantomx GMBH. The Government intends to issue a sole source award in accordance with FAR 6.302-1, only one responsible source and no other will satisfy the agency requirements for the above stated service.



The scope of the work is to provide breast phantoms. One phantom shall have a uniform background breast shape emulating x-ray attenuation of adipose tissue with 10, 10 mm long cylinders of radius 5 mm, two masses with each iodine concentration of 0.25 mg/ml, 0.5 mg/ml, 1.0 mg/ml, and 2.0 mg/ml

The other four phantoms shall have anthropomorphic breast background structure matching a virtual breast phantom supplied by the FDA.



The NAICS Code is: 334516 Analytical Laboratory Instrument Manufacturing.



The Vendor to be awarded:



Phantomx GMBH

Schwedenster.14

Berlin

Germany



This will be a firm fixed price award for a Base Period and four (4) one (1) year Option Periods.



This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement to Iris Johnson, Iris.Johnson1@fda.hhs.gov in writing and must be within five (5) days after date of publication of this notice which may be considered by the agency. A determination by the Government not to compete as a result of information received is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.



No phone calls will be accepted.
Active Contract Opportunity
Notice ID : 75F40123Q00399
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : FOOD AND DRUG ADMINISTRATION
Office : FDA OFFICE OF ACQ GRANT SVCS
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Sep 11, 2023 10:40 pm EDT
Original Response Date: Sep 18, 2023 10:00 am EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Oct 03, 2023
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6640 - LABORATORY EQUIPMENT AND SUPPLIES
NAICS Code: 334516 - Analytical Laboratory Instrument Manufacturing

Place of Performance:

Documents

 Tender Notice

NOI_CDRH-2023-117782.pdf


Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA


Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services


View Tenders By


Publish Tenders


Have Any Dispute With The Purchaser?